FDA approval of Zelboraf(TM) (vemurafenib) establishes oncology foothold in US for Daiichi Sankyo
17 August 2011 | By Daiichi Sankyo
First-in-class treatment option soon available to treat deadly form of skin cancer...
List view / Grid view
News
FDA approves Zelboraf (vemurafenib)
17 August 2011 | By Roche
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma...
Tecan’s MCA 384 adapter plate concept provides ultimate flexibility
16 August 2011 | By kdm communications
The flexibility offered by Tecan’s MultiChannel Arm™ (MCA) 384 and Freedom EVO® liquid handling platform is vital to researchers...
FDA approve two three-month strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension)
16 August 2011 | By Abbott
Two strengths for three-month administration of Lupron Depot-PED ® approved...
Bristol-Myers Squibb announces winners of “Fight HIV Your Way” contest
16 August 2011 | By Bristol-Myers Squibb Company
Winners of the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” contest announced...
Pfizer wins Viagra patent trial
15 August 2011 | By Pfizer
Pfizer Inc. has prevailed in its patent infringement action against Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of VA...
GSK and Impax announce positive topline results of ASCEND-PD Phase III study of IPX066 in Advanced Parkinson’s disease
15 August 2011 | By GlaxoSmithKline
Top-line results of the ASCEND-PD Phase III clinical study...
Gilead’s investigational antiretroviral Quad regimen meets 48-week primary objective in pivotal Phase 3 Clinical Study 102
15 August 2011 | By Gilead Sciences
Phase 3 clinical trial met its primary objective...
“Drug hunter” honoured
11 August 2011 | By University of Brighton
One of the world’s most renowned “drug hunters” has been awarded an honorary Doctor of Science from the University of Brighton...
Abbott receives U.S. FDA approval for RX Herculink Elite® Renal Stent System
10 August 2011 | By Abbott
The U.S. FDA approved the RX Herculink Elite® Renal Stent System for the treatment of renal artery stenosis...
GSK and Enigma Diagnostics announce collaboration
10 August 2011 | By GlaxoSmithKline
GSK & Enigma Diagnostics have signed agreements for the supply & commercialisation of the Enigma® ML system...
Greenphire contracts with the University of Kansas to automate clinical payment and communication processes
10 August 2011 | By The Scott Partnership
The University of Kansas (KU) implement Greenphire's patent-pending ClinCard System...
Boehringer Ingelheim licenses ProBioGen’s novel GlymaxX® technology
10 August 2011 | By Boehringer Ingelheim
Boehringer Ingelheim and ProBioGen AG have signed a non-exclusive Licensing Agreement regarding ProBioGen’s GlymaxX® technology...
U.S. FDA approves Gilead Sciences’ Complera™
10 August 2011 | By Gilead Sciences Inc
A new complete once-daily, single-tablet regimen for HIV-1 infection in treatment-naïve adults...
Lilly announces review of data on long-term raloxifene treatment
9 August 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published...
